This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
ThousandOaks- and Shanghai-based ThousandOaks Biopharmaceuticals , a new contract manufacturing organization fort he biotech industry, said it has received $45M in a Series A financing round.
ThousandOaks-based Xirrus , a developer of Wi-Fi networking hardware, has raised another $20M in funding, according to a regulatory filing from the firm today. Details on the new funding have not yet been announced by the company. Tags: hardware networking wifi capital venture xirrus. READ MORE>>.
ThousandOaks-based Xirrus confirmed Tuesday that it has raised an additional $20M in funding, bringing the firm's total raised to $80M. Xirrus said the new funding would bolster its reserves, and would go towards partnerships with large integrators. The round was led by InterWest Partners. READ MORE>>.
ThousandOaks-based wireless hardware provider Xirrus has raised yet another $10M in funding, according to a regulatory filing from the company Monday. Details on the funding have not yet been announced by the company. in the funding round, which so far includes 12 investors. Venture Partners. READ MORE>>.
ThousandOaks-based biopharmaceuticals startup Atara Biotherapeutics announced this morning that it has raised $38.5M in a Series B funding round, for its efforts to develop treatments for patients with end-stage renal disease. atara biotherapeutics venture capital renal disease lifescience amgen' READ MORE>>.
Xirrus , the wireless hardware provider based in ThousandOaks, has just raised $10.1M in a funding round, part of an ongoing $11.0M funding, according to a regulatory filing by the company. Details on the funding have not yet been announced by the company.
ThousandOaks-based Ceres , a developer of biofuel crop technology, has raised another $20M in funding, according to a regulatory filing from the firm Friday. Source of the new funding was not disclosed. Tags: warburg capital venture clean cleantech energy biofuel ceres. READ MORE>>.
ThousandOaks-based ImmunGene , a startup biotech company developing antibody-based, protein therapeutics for treating cancer, said today that it has raised $9M in a Series A funding, to advance its early stage development products. According to the company, the funding came from Ally Bridge Group. READ MORE>>.
ThousandOaks-based Atara Biotherapeutics announced this morning that it is in a second close of its Series B funding round, bringing its total raised in the funding to $52M. amgen lifescience disease renal capital venture biotherapeutics atara' READ MORE>>.
ThousandOaks-based Xirrus , the developer of high speed, high performance wireless networking hardware, has raised another big chunk of financing, saying today that it has raised $23.5M in a Series E funding round. Xirrus said the funding will go towards sales growth and its product.
Amgen Ventures , the venture investment arm of ThousandOaks-based Amgen , is one of the new investors in precision oncology and medicine startup Syapse. READ MORE>>.
ThousandOaks-based wireless equipment maker Xirrus appears to have raised $18.4M more in a funding round, part of an ongoing $25.3M funding, according to a regulatory filing by the company. READ MORE>>.
Amgen Ventures , the venture capital arm of ThousandOaks-based Amgen , has backed the developer of a biopharmaceutical aimed at treating irritable bowel syndrome, kidney disease, and diabetes.
San Diego-based Ocean Aero , a developer of unmanned, autonomous marine vehicles, has scored funding from ThousandOaks-based Teledyne , the companies said this morning. investment strategic capital venture marine ocean ship robot autonomous robotic oceanaero aero' Financial terms of the investment were not disclosed.
The venture capital arm of ThousandOaks-based Amgen has placed more funding into one of its portfolio companies, Sutro Biopharma , which is working on developing a scalable biochemical protein synthesis platform aimed at cancer therapeutics. Sutro said it has raised $16.5M
ThousandOaks-based Capsida Biotherapeutics, a new biotechnology company focused on using adeno-associated virus (AAV) engineering and cargo development platform to develop tissue-targeted gene therapies for multiple types of diseases, has uncloaked from stealth mode, saying it has raised $140M in total capital.
Amgen Ventures , the venture capital arm of ThousandOaks-based Amgen , is one of the investors in a Boston biotech company, Akili Interactive. Akili is developing digital medicine products aimed at treating cognitive dysfunction, including ADHD, multiple sclerosis, and depression. READ MORE>>.
ThousandOaks-based Ceres , a developer of biofuels crop technology, said Thursday that it has completed a private offering of convertible preferred stock. The funding came from Artal Luxembourg, Ambergate Trust, Gimv, and other undisclosed investors. Ceres is developing improved seed varieties--including. READ MORE>>.
ThousandOaks-based Amgen has made another investment this morning in immunology startup Tizona Therapeutics , via its venture capital arm, Amgen Ventures. Series A investors--including Amgen Ventures--also participated, with investments from MPM Capital, Astellas Venture Management and InterWest Partners. READ MORE>>.
ThousandOaks-based Amgen has helped to back a new, life sciences fund, managed by San Francisco-based venBio , as an anchor supporter of a new fund. venBio did not say how much Amgen committed to the fund, which is venBio's second life sciences fund. READ MORE>>.
YouMail is led by Alex Quilici, and backed by VantagePoint Capital Partners, the Tech Coast Angels, the Tech Coast Angels ACE Fund, Siemer Ventures, and the CrunchFund. Red Pocket Mobile is based in ThousandOaks. The two said that Red Pocket Mobile's customers can now access YouMail from any compatible GSM phone.
ThousandOaks-based drug development company Atara Biotherapeutics announced this morning that it has added Matthew K. Fust as a board member, and hired Mitchall G. Clark as its Chief Regulatory and Quality Assurance Officer. READ MORE>>. atara biotherapeutics renal disease lifescience amgen executive board'
The latest numbers from the MoneyTree Report from PricewaterhouseCoopers and the National Venture Capital Association (NVCA), based on data from Thomson Reuters, were released this morning, finding that there was $587.8M Tags: venture capital investment quarterly moneytree thomson reuters. invested in Southern California in Q4.
South San Francisco-based Alector , a biotechnology company focused on finding treatments for neurodegenerative diseases and cancer, announced Wednesday that it has raised $133M in a Series E funding round. Alector said the financing will go to advance its clinical programs and expand the company's discovery platform. READ MORE>>.
ThousandOaks-based wireless networking equipment maker Xirrus has been acquired by Riverbed , to help bolster its SD WAN efforts, the two said on Wednesday. Financial terms of the acquisition were not announced. Riverbed said it will continue to offer up Xirrus as a stand-alone enterprise WLAN solution.
ThousandOaks-based Amgen has returned as one of the investors in cancer therapeutis developer Sutro Biopharma , as part of an $85.4M funding round. in a Series E funding round. South San Francisco-based Sutro Biopharma said last week that it has raised $85.4M
ThousandOaks-based Amgen is the lead investor in a round for San Francisco- and Bozeman, Montana-based SiteOne Therapeutics , SiteOne said on Friday. SiteOne said it raised $15M in a Series B funding round, which was led b Amgen, and also included Next Frontier Capital and insiders.
ThousandOaks-based biotech giant Amgen is the a new investor in a round for Alector , a developer of immuno-modulatory therapies for Alzheimer's disease and other neurogenerative disorders, which announced a $29.5M funding today. READ MORE>>.
ThousandOaks-based Amgen has seen an exit out of its startup investment portfolio, and activities of its Amgen Ventures venture capital arm, at Berkeley-based Adheron Therapeutics this morning. Adheron said that it has been acquired by Roche , in a deal worth $105M upfront and up to $475M in additional milestone payments.
ThousandOaks-based Akriveia Therapeutics , a biotechnology startup focused on immuno-oncology, announced this morning that it has raised $7.5M The investment came from F-Prime Capital Partners. As part of the funding, F-Prime's Thomas Beck and Ben Auspitz have joined the company's board. in a Series A investment.
YouMail is led by Alex Quilici, and backed by VantagePoint Capital Partners, the Tech Coast Angels, the Tech Coast Angels ACE Fund, Siemer Ventures, and the CrunchFund. Red Pocket Mobile is based in ThousandOaks. The two said that Red Pocket Mobile's customers can now access YouMail from any compatible GSM phone.
The latest numbers from the MoneyTree Report from PricewaterhouseCoopers and the National Venture Capital Association (NVCA), based on data from Thomson Reuters, were released this morning, finding that there was $587.8M Tags: reuters thomson moneytree quarterly investment capital venture. invested in Southern California in Q4.
ThousandOaks-based Dantari has raised $47M in its Series A funding, saying that it has launched a new, clinical-stage biotechnology company developing targeted therapeutics for the treatment of cancers and other diseases.
• Jack Gilbert , once the chief executive officer of a large Los Angeles-based corporation, later founded ThousandOaks Land Development and played a major role in the development of ThousandOaks area, leading that city’s emergence as a major business and corporate center.
in a funding round. I grew up in ThousandOaks, went to USC, and we met each other way back in the 90's. Investors get access to deals and loans, and lenders get more access to capital, borrower get better rates, and it benefits everyone. Brew Johnson: It's exciting to be building this business in LA.
. —In other financing news: Synthorx , a San Diego synthetic biology startup, got a $10 million investment led by RA Capital Management…The venture arms of Merck and Amgen backed therapeutic video game developer Akili Interactive , bumping its Series B up to $42.4
George Rathmann , the founding CEO of ThousandOaks biotech giant Amgen , has died, the company announced late Monday evening. Rathman helped secure Amgen's venture capitalfunding and guide Amgen to its IPO, as well as growing the company to one of the largest biotech firms in the world.
We organize all of the trending information in your field so you don't have to. Join 5,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content